Annual report pursuant to Section 13 and 15(d)

Discontinued Operations

v3.22.1
Discontinued Operations
12 Months Ended
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

 

4. Discontinued Operations

 

The Company accounts for business dispositions and its businesses held for sale in accordance with ASC 205-20, Discontinued Operations. ASC 205-20 requires the results of operations of business dispositions to be segregated from continuing operations and reflected as discontinued operations in current and prior periods.

 

The components of liabilities classified as discontinued operations relate to Commercial Services and consist of the following as of December 31, 2021 and December 31, 2020:

 

    December 31,
2021
    December 31,
2020
 
             
Accrued liabilities   $    766     $    766  
Current liabilities from discontinued operations     766       766  
Total liabilities   $ 766     $ 766  

 

The table below presents the significant components of CSO, Group DCA’s, Pharmakon’s and TVG’s results included within loss from discontinued operations, net of tax in the consolidated statements of operations for the years ended December 31, 2021 and 2020.

 

    2021     2020  
    Years Ended  
    December 31,  
    2021     2020  
Income from discontinued operations, before tax   $ -     $ -  
Income tax expense     197       250  
Loss from discontinued operations, net of tax   $ (197 )   $ (250 )